IEQ Capital’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $210K | Buy |
186,178
+120,000
| +181% | +$136K | ﹤0.01% | 1590 |
|
|
2025
Q1 | $96.6K | Hold |
66,178
| – | – | ﹤0.01% | 1484 |
|
|
2024
Q4 | $141K | Hold |
66,178
| – | – | ﹤0.01% | 1245 |
|
|
2024
Q3 | $185K | Hold |
66,178
| – | – | ﹤0.01% | 1069 |
|
|
2024
Q2 | $154K | Sell |
66,178
-175
| -0.3% | -$408 | ﹤0.01% | 932 |
|
|
2024
Q1 | $297K | Hold |
66,353
| – | – | ﹤0.01% | 774 |
|
|
2023
Q4 | $213K | Buy |
66,353
+175
| +0.3% | +$562 | ﹤0.01% | 825 |
|
|
2023
Q3 | $210K | Buy |
66,178
+20,648
| +45% | +$65.5K | ﹤0.01% | 825 |
|
|
2023
Q2 | $226K | Buy |
45,530
+2,530
| +6% | +$12.6K | ﹤0.01% | 774 |
|
|
2023
Q1 | $212K | Buy |
43,000
+21,000
| +95% | +$104K | ﹤0.01% | 805 |
|
|
2022
Q4 | $138K | Sell |
22,000
-21,000
| -49% | -$132K | ﹤0.01% | 755 |
|
|
2022
Q3 | $464K | Hold |
43,000
| – | – | 0.01% | 549 |
|
|
2022
Q2 | $490K | Hold |
43,000
| – | – | 0.01% | 478 |
|
|
2022
Q1 | $392K | Hold |
43,000
| – | – | 0.01% | 565 |
|
|
2021
Q4 | $642K | Sell |
43,000
-47
| -0.1% | -$702 | 0.01% | 400 |
|
|
2021
Q3 | $1.11M | Buy |
43,047
+47
| +0.1% | +$1.21K | 0.03% | 279 |
|
|
2021
Q2 | $1.12M | Hold |
43,000
| – | – | 0.03% | 239 |
|
|
2021
Q1 | $1.52M | Hold |
43,000
| – | – | 0.06% | 165 |
|
|
2020
Q4 | $1.09M | Hold |
43,000
| – | – | 0.05% | 160 |
|
|
2020
Q3 | $1.62M | Hold |
43,000
| – | – | 0.09% | 125 |
|
|
2020
Q2 | $1.84M | Hold |
43,000
| – | – | 0.12% | 110 |
|
|
2020
Q1 | $836K | Hold |
43,000
| – | – | 0.07% | 161 |
|
|
2019
Q4 | $1.12M | Buy |
+43,000
| New | +$1.12M | 0.1% | 140 |
|